1. Home
  2. ARBB vs SNGX Comparison

ARBB vs SNGX Comparison

Compare ARBB & SNGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ARBB
  • SNGX
  • Stock Information
  • Founded
  • ARBB 1997
  • SNGX 1987
  • Country
  • ARBB Singapore
  • SNGX United States
  • Employees
  • ARBB N/A
  • SNGX N/A
  • Industry
  • ARBB EDP Services
  • SNGX Biotechnology: Pharmaceutical Preparations
  • Sector
  • ARBB Technology
  • SNGX Health Care
  • Exchange
  • ARBB Nasdaq
  • SNGX Nasdaq
  • Market Cap
  • ARBB 8.8M
  • SNGX 10.1M
  • IPO Year
  • ARBB 2023
  • SNGX 1987
  • Fundamental
  • Price
  • ARBB $4.82
  • SNGX $2.81
  • Analyst Decision
  • ARBB Strong Buy
  • SNGX Strong Buy
  • Analyst Count
  • ARBB 1
  • SNGX 1
  • Target Price
  • ARBB $20.00
  • SNGX $6.00
  • AVG Volume (30 Days)
  • ARBB 7.4K
  • SNGX 659.7K
  • Earning Date
  • ARBB 11-03-2025
  • SNGX 11-07-2025
  • Dividend Yield
  • ARBB N/A
  • SNGX N/A
  • EPS Growth
  • ARBB N/A
  • SNGX N/A
  • EPS
  • ARBB N/A
  • SNGX N/A
  • Revenue
  • ARBB $24,425,491.00
  • SNGX N/A
  • Revenue This Year
  • ARBB N/A
  • SNGX N/A
  • Revenue Next Year
  • ARBB $462.92
  • SNGX N/A
  • P/E Ratio
  • ARBB N/A
  • SNGX N/A
  • Revenue Growth
  • ARBB N/A
  • SNGX N/A
  • 52 Week Low
  • ARBB $3.62
  • SNGX $1.09
  • 52 Week High
  • ARBB $18.60
  • SNGX $6.23
  • Technical
  • Relative Strength Index (RSI)
  • ARBB 53.37
  • SNGX 49.49
  • Support Level
  • ARBB $4.55
  • SNGX $2.58
  • Resistance Level
  • ARBB $4.94
  • SNGX $2.98
  • Average True Range (ATR)
  • ARBB 0.23
  • SNGX 0.19
  • MACD
  • ARBB 0.07
  • SNGX -0.07
  • Stochastic Oscillator
  • ARBB 84.07
  • SNGX 35.94

About ARBB ARB IOT Group Limited

ARB IOT Group Ltd is engaged in provision of hardware and software of Internet of Things Solutions to meet customers' demand in four business lines, which are IoT Smart Home and Buildings, IoT Smart Agriculture, IoT System Development, and IoT Gadget Distribution. The company delivers holistic solutions with full turnkey deployment from designing, installation, testing, pre-commissioning, and commissioning of various IoT systems and devices as well as integration of automated systems, including installation of wire and wireless and mechatronic works. The company has two operating segments: Internet of Things ('IoT'), Investment holding and others. It earns its maximum profit from the Internet of Things (IoT) segment.

About SNGX Soligenix Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely Specialized BioTherapeutics and Public Health Solutions. It generates maximum revenue from Public Health Solutions with active development programs for RiVax, its ricin toxin vaccine candidate, SGX943, its therapeutic candidate for antibiotic resistant and emerging infectious disease, and its research programs to identify and develop novel vaccine candidates targeting viral infection including Ebola, Marburg and SARS-CoV-2 (the cause of COVID-19).

Share on Social Networks: